Investindustrial

MTD acquires Ypsomed's pen needle and BGM businesses, strengthening its leading position in diabetes care

Retrieved on: 
星期三, 三月 27, 2024

MILAN, March 27, 2024 /PRNewswire/ -- MTD (Medical Technology and Devices), a leading provider of medical technology solutions for self-care and professional use worldwide, announces the acquisition Ypsomed's pen needle and blood glucose monitoring (BGM) businesses.

Key Points: 
  • MILAN, March 27, 2024 /PRNewswire/ -- MTD (Medical Technology and Devices), a leading provider of medical technology solutions for self-care and professional use worldwide, announces the acquisition Ypsomed's pen needle and blood glucose monitoring (BGM) businesses.
  • This strategic move solidifies MTD's position as a globally leading player in pen needle production and enhances its comprehensive solution portfolio for diabetes care.
  • MTD, the second largest manufacturer of pen needles globally, will incorporate in its operations the pen needle and BGMs portfolio from Ypsomed - a leading developer and manufacturer of injection and infusion systems for self-medication for 40 years.
  • Charles Bouaziz, CEO of MTD, expresses enthusiasm for the partnership with Ypsomed and the opportunities it brings.

MTD acquires Ypsomed's pen needle and BGM businesses, strengthening its leading position in diabetes care

Retrieved on: 
星期三, 三月 27, 2024

MILAN, March 27, 2024 /PRNewswire/ -- MTD (Medical Technology and Devices), a leading provider of medical technology solutions for self-care and professional use worldwide, announces the acquisition Ypsomed's pen needle and blood glucose monitoring (BGM) businesses.

Key Points: 
  • MILAN, March 27, 2024 /PRNewswire/ -- MTD (Medical Technology and Devices), a leading provider of medical technology solutions for self-care and professional use worldwide, announces the acquisition Ypsomed's pen needle and blood glucose monitoring (BGM) businesses.
  • This strategic move solidifies MTD's position as a globally leading player in pen needle production and enhances its comprehensive solution portfolio for diabetes care.
  • MTD, the second largest manufacturer of pen needles globally, will incorporate in its operations the pen needle and BGMs portfolio from Ypsomed - a leading developer and manufacturer of injection and infusion systems for self-medication for 40 years.
  • Charles Bouaziz, CEO of MTD, expresses enthusiasm for the partnership with Ypsomed and the opportunities it brings.

Eataly Appoints New CEO North America

Retrieved on: 
星期二, 九月 26, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230926270130/en/
    Eataly Appoints New CEO North America.
  • Prior to that, he was CEO of Diesel North America from 2013-2017, CEO of Furla Americas from 2008-2013, and CEO of Fedon for the United States from 2004-2008.
  • “To continue with the Group’s growth in North America we are welcoming an Italian Manager with great experience in the USA like Tommaso Brusò.” – Comments Andrea Cipolloni, Group CEO Eataly – “Given our significant growth ambitions in North America, the CEO North America position is a newly created role.
  • The new CEO North America appointment follows the appointment of Eataly Group CEO, Andrea Cipolloni in November 2022 and the subsequent senior management appointments of a new CFO, COO and Head of HR earlier this year.

Paul, Weiss Enhances Private Equity Capabilities With Arrival of Market-Leading Transactional Teams in London, New York and Los Angeles

Retrieved on: 
星期一, 九月 11, 2023

Paul, Weiss announced today that 13 prominent private equity transactional partners are joining the firm to significantly expand its global private equity practices, led by Neel V. Sachdev and Roger Johnson in London and Eric J. Wedel in New York and Los Angeles.

Key Points: 
  • Paul, Weiss announced today that 13 prominent private equity transactional partners are joining the firm to significantly expand its global private equity practices, led by Neel V. Sachdev and Roger Johnson in London and Eric J. Wedel in New York and Los Angeles.
  • Roger has long advised global private equity firms and financial sponsor clients on all forms of cross-border leveraged M&A and portfolio assistance, including restructuring advice.
  • Will regularly advises on the most complex cross-border private equity transactions in the region, including private M&A, buyouts, carve-outs, co-investments, consortium deals and distressed acquisitions.
  • His clients include TDR Capital, Hillhouse Investment, I Squared Capital, and numerous other major private equity firms.

Zegna Group & Investindustrial Acquisition Corp. Complete Business Combination to List World-Renowned Global Luxury Group on New York Stock Exchange

Retrieved on: 
星期五, 十二月 17, 2021

Ermenegildo Zegna N.V. (Zegna, the Group or the Company), the world-renowned Italian luxury group, today announced the completion of its business combination with Investindustrial Acquisition Corp. (NYSE:IIAC) (IIAC), a special purpose acquisition corporation sponsored by investment subsidiaries of Investindustrial VII L.P.

Key Points: 
  • Ermenegildo Zegna N.V. (Zegna, the Group or the Company), the world-renowned Italian luxury group, today announced the completion of its business combination with Investindustrial Acquisition Corp. (NYSE:IIAC) (IIAC), a special purpose acquisition corporation sponsored by investment subsidiaries of Investindustrial VII L.P.
  • Ermenegildo Zegna, CEO of Zegna Group, will ring the opening bell at the New York Stock Exchange at 9:30 am Eastern Time on Monday, December 20, 2021.
  • Ermenegildo Gildo Zegna, CEO of Zegna Group, said: Today marks a monumental milestone for Zegna and is the beginning of an exciting and pivotal new chapter in our 111-year legacy.
  • Our Road has now led us to New York, where the Group will be listed on the New York Stock Exchange.

Hexion Inc. Completes Sale of Phenolic Specialty Resins, Hexamine and European-based Forest Products Resins Businesses to Black Diamond and Investindustrial

Retrieved on: 
星期五, 四月 30, 2021

b'Hexion Inc. (\xe2\x80\x9cHexion\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) today announced that it has completed the sale of its Phenolic Specialty Resin, Hexamine and European-based Forest Products Resins businesses for approximately $425 million to Black Diamond and Investindustrial.

Key Points: 
  • b'Hexion Inc. (\xe2\x80\x9cHexion\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) today announced that it has completed the sale of its Phenolic Specialty Resin, Hexamine and European-based Forest Products Resins businesses for approximately $425 million to Black Diamond and Investindustrial.
  • In addition, our management may from time to time make oral forward-looking statements.
  • Additional information about Hexion Inc. and its products is available at www.hexion.com .\nBlack Diamond Capital Management, L.L.C.
  • Black Diamond has over 25 years of experience in underwriting, trading, restructuring and managing performing, stressed, distressed and private equity investments through multiple market cycles.

Hexion Inc. Announces Updated Timing for Sale of Phenolic Specialty Resins, Hexamine and European-based Forest Products Resins Businesses to Black Diamond and Investindustrial

Retrieved on: 
星期三, 三月 31, 2021

In addition, our management may from time to time make oral forward-looking statements.

Key Points: 
  • In addition, our management may from time to time make oral forward-looking statements.
  • All statements, other than statements of historical facts, are forward-looking statements.
  • Forward-looking statements may be identified by the words believe, expect, anticipate, project, might, plan, estimate, may, will, could, should, seek or intend and similar expressions.
  • Investindustrial is a leading European group of independently managed investment, holding and advisory companies with 11 billion of raised fund capital.

Hexion Inc. Announces Agreement for Sale of Phenolic Specialty Resins, Hexamine and European-based Forest Products Resins Businesses to Black Diamond and Investindustrial

Retrieved on: 
星期一, 九月 28, 2020

Hexion Inc. (Hexion or the Company) today announced that it has entered into a definitive agreement to sell its Phenolic Specialty Resin, Hexamine and European-based Forest Products Resins businesses for approximately $425 million to Black Diamond and Investindustrial.

Key Points: 
  • Hexion Inc. (Hexion or the Company) today announced that it has entered into a definitive agreement to sell its Phenolic Specialty Resin, Hexamine and European-based Forest Products Resins businesses for approximately $425 million to Black Diamond and Investindustrial.
  • As we proceed, we will leverage our differentiated technology and global manufacturing footprint to serve the diversified customers of our remaining businesses.
  • On behalf of everyone at Hexion, I would like to thank our associates within our Phenolic Specialty Resins, Hexamine and European-based Forest Products Resins businesses for their many contributions.
  • Finally, Black Diamond has prior experience investing in phenolic specialty resin businesses and looks forward to bringing that experience to the acquired businesses.